[Experience using tidazin--a new Russian selective stimulant of histamine H2 receptors]. 1986

F I Komarov, and L K Gavrovskaia, and M S Sukirno, and M Iu Melikova, and Iu V Anshelevich

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010437 Peptic Ulcer Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS). Gastroduodenal Ulcer,Marginal Ulcer,Gastroduodenal Ulcers,Marginal Ulcers,Peptic Ulcers,Ulcer, Gastroduodenal,Ulcer, Marginal,Ulcer, Peptic,Ulcers, Gastroduodenal,Ulcers, Marginal,Ulcers, Peptic
D011968 Receptors, Histamine Cell-surface proteins that bind histamine and trigger intracellular changes influencing the behavior of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognized and designated H1, H2, and H3. They differ in pharmacology, distribution, and mode of action. Histamine Binding Sites,Histamine Receptors,Histamine Receptor,Binding Sites, Histamine,Receptor, Histamine,Sites, Histamine Binding
D011970 Receptors, Histamine H2 A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H2 receptors act via G-proteins to stimulate ADENYLYL CYCLASES. Among the many responses mediated by these receptors are gastric acid secretion, smooth muscle relaxation, inotropic and chronotropic effects on heart muscle, and inhibition of lymphocyte function. (From Biochem Soc Trans 1992 Feb;20(1):122-5) Histamine H2 Receptors,H2 Receptors,Receptors, H2,H2 Receptors, Histamine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004382 Duodenitis Inflammation of the DUODENUM section of the small intestine (INTESTINE, SMALL). Erosive duodenitis may cause bleeding in the UPPER GI TRACT and PEPTIC ULCER. Erosive Duodenitis,Duodenitis, Erosive
D005260 Female Females
D005744 Gastric Acid Hydrochloric acid present in GASTRIC JUICE. Hydrochloric Acid, Gastric,Acids, Gastric,Acids, Gastric Hydrochloric,Gastric Acids,Gastric Hydrochloric Acid,Gastric Hydrochloric Acids,Hydrochloric Acids, Gastric
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland

Related Publications

F I Komarov, and L K Gavrovskaia, and M S Sukirno, and M Iu Melikova, and Iu V Anshelevich
December 1976, Il Farmaco; edizione scientifica,
F I Komarov, and L K Gavrovskaia, and M S Sukirno, and M Iu Melikova, and Iu V Anshelevich
August 1982, Lancet (London, England),
F I Komarov, and L K Gavrovskaia, and M S Sukirno, and M Iu Melikova, and Iu V Anshelevich
October 1988, The American review of respiratory disease,
F I Komarov, and L K Gavrovskaia, and M S Sukirno, and M Iu Melikova, and Iu V Anshelevich
February 1998, General pharmacology,
F I Komarov, and L K Gavrovskaia, and M S Sukirno, and M Iu Melikova, and Iu V Anshelevich
February 2007, Neuroscience research,
F I Komarov, and L K Gavrovskaia, and M S Sukirno, and M Iu Melikova, and Iu V Anshelevich
July 1979, British journal of pharmacology,
F I Komarov, and L K Gavrovskaia, and M S Sukirno, and M Iu Melikova, and Iu V Anshelevich
December 1979, Life sciences,
F I Komarov, and L K Gavrovskaia, and M S Sukirno, and M Iu Melikova, and Iu V Anshelevich
January 1978, Advances in experimental medicine and biology,
F I Komarov, and L K Gavrovskaia, and M S Sukirno, and M Iu Melikova, and Iu V Anshelevich
November 1988, Allergie et immunologie,
F I Komarov, and L K Gavrovskaia, and M S Sukirno, and M Iu Melikova, and Iu V Anshelevich
January 1979, Circulatory shock,
Copied contents to your clipboard!